Selected research
Market Analysis & Forecast
Global Tenapanor Market Analysis and Forecast 2026-2032
Market perspective
The global Tenapanor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tenapanor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Tenapanor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Tenapanor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Tenapanor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Tenapanor include Kyowa Kirin, Fosun Pharma and Ardelyx, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Tenapanor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Tenapanor, also provides the sales of main regions and countries. Of the upcoming market potential for Tenapanor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tenapanor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tenapanor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tenapanor sales, projected growth trends, production technology, application and end-user industry.
Tenapanor Segment by Company
Kyowa Kirin
Fosun Pharma
Ardelyx
Tenapanor Segment by Type
10mg per Tablet
20mg per Tablet
30mg per Tablet
50mg per Tablet
Tenapanor Segment by Application
Irritable Bowel Syndrome with Constipation
Hyperphosphatemia
Other
Tenapanor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tenapanor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tenapanor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tenapanor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Tenapanor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Tenapanor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tenapanor sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg per Tablet
- 20mg per Tablet
- 30mg per Tablet
- 50mg per Tablet
Applications
- Irritable Bowel Syndrome with Constipation
- Hyperphosphatemia
- Other
Companies covered
- Kyowa Kirin
- Fosun Pharma
- Ardelyx
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Tenapanor Market by Type
- 1.2.1 Global Tenapanor Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 10mg per Tablet
- 1.2.3 20mg per Tablet
- 1.2.4 30mg per Tablet
- 1.2.5 50mg per Tablet
- 1.3 Tenapanor Market by Application
- 1.3.1 Global Tenapanor Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Irritable Bowel Syndrome with Constipation
- 1.3.3 Hyperphosphatemia
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Tenapanor Market Dynamics
- 2.1 Tenapanor Industry Trends
- 2.2 Tenapanor Industry Drivers
- 2.3 Tenapanor Industry Opportunities and Challenges
- 2.4 Tenapanor Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Tenapanor Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Tenapanor Revenue by Region
- 3.2.1 Global Tenapanor Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Tenapanor Revenue by Region (2021-2026)
- 3.2.3 Global Tenapanor Revenue by Region (2027-2032)
- 3.2.4 Global Tenapanor Revenue Market Share by Region (2021-2032)
- 3.3 Global Tenapanor Sales Estimates and Forecasts 2021-2032
- 3.4 Global Tenapanor Sales by Region
- 3.4.1 Global Tenapanor Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Tenapanor Sales by Region (2021-2026)
- 3.4.3 Global Tenapanor Sales by Region (2027-2032)
- 3.4.4 Global Tenapanor Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Tenapanor Revenue by Manufacturers
- 4.1.1 Global Tenapanor Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Tenapanor Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Tenapanor Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Tenapanor Sales by Manufacturers
- 4.2.1 Global Tenapanor Sales by Manufacturers (2021-2026)
- 4.2.2 Global Tenapanor Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Tenapanor Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Tenapanor Sales Price by Manufacturers (2021-2026)
- 4.4 Global Tenapanor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Tenapanor Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Tenapanor Manufacturers, Product Type & Application
- 4.7 Global Tenapanor Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Tenapanor Market CR5 and HHI
- 4.8.2 2025 Tenapanor Tier 1, Tier 2, and Tier 3
5 Tenapanor Market by Type
- 5.1 Global Tenapanor Revenue by Type
- 5.1.1 Global Tenapanor Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Tenapanor Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Tenapanor Revenue Market Share by Type (2021-2032)
- 5.2 Global Tenapanor Sales by Type
- 5.2.1 Global Tenapanor Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Tenapanor Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Tenapanor Sales Market Share by Type (2021-2032)
- 5.3 Global Tenapanor Price by Type
6 Tenapanor Market by Application
- 6.1 Global Tenapanor Revenue by Application
- 6.1.1 Global Tenapanor Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Tenapanor Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Tenapanor Revenue Market Share by Application (2021-2032)
- 6.2 Global Tenapanor Sales by Application
- 6.2.1 Global Tenapanor Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Tenapanor Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Tenapanor Sales Market Share by Application (2021-2032)
- 6.3 Global Tenapanor Price by Application
7 Company Profiles
- 7.1 Kyowa Kirin
- 7.1.1 Kyowa Kirin Company Information
- 7.1.2 Kyowa Kirin Business Overview
- 7.1.3 Kyowa Kirin Tenapanor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Kyowa Kirin Tenapanor Product Portfolio
- 7.1.5 Kyowa Kirin Recent Developments
- 7.2 Fosun Pharma
- 7.2.1 Fosun Pharma Company Information
- 7.2.2 Fosun Pharma Business Overview
- 7.2.3 Fosun Pharma Tenapanor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Fosun Pharma Tenapanor Product Portfolio
- 7.2.5 Fosun Pharma Recent Developments
- 7.3 Ardelyx
- 7.3.1 Ardelyx Company Information
- 7.3.2 Ardelyx Business Overview
- 7.3.3 Ardelyx Tenapanor Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Ardelyx Tenapanor Product Portfolio
- 7.3.5 Ardelyx Recent Developments
8 North America
- 8.1 North America Tenapanor Market Size by Type
- 8.1.1 North America Tenapanor Revenue by Type (2021-2032)
- 8.1.2 North America Tenapanor Sales by Type (2021-2032)
- 8.1.3 North America Tenapanor Price by Type (2021-2032)
- 8.2 North America Tenapanor Market Size by Application
- 8.2.1 North America Tenapanor Revenue by Application (2021-2032)
- 8.2.2 North America Tenapanor Sales by Application (2021-2032)
- 8.2.3 North America Tenapanor Price by Application (2021-2032)
- 8.3 North America Tenapanor Market Size by Country
- 8.3.1 North America Tenapanor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Tenapanor Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Tenapanor Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Tenapanor Market Size by Type
- 9.1.1 Europe Tenapanor Revenue by Type (2021-2032)
- 9.1.2 Europe Tenapanor Sales by Type (2021-2032)
- 9.1.3 Europe Tenapanor Price by Type (2021-2032)
- 9.2 Europe Tenapanor Market Size by Application
- 9.2.1 Europe Tenapanor Revenue by Application (2021-2032)
- 9.2.2 Europe Tenapanor Sales by Application (2021-2032)
- 9.2.3 Europe Tenapanor Price by Application (2021-2032)
- 9.3 Europe Tenapanor Market Size by Country
- 9.3.1 Europe Tenapanor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Tenapanor Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Tenapanor Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Tenapanor Market Size by Type
- 10.1.1 China Tenapanor Revenue by Type (2021-2032)
- 10.1.2 China Tenapanor Sales by Type (2021-2032)
- 10.1.3 China Tenapanor Price by Type (2021-2032)
- 10.2 China Tenapanor Market Size by Application
- 10.2.1 China Tenapanor Revenue by Application (2021-2032)
- 10.2.2 China Tenapanor Sales by Application (2021-2032)
- 10.2.3 China Tenapanor Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Tenapanor Market Size by Type
- 11.1.1 Asia Tenapanor Revenue by Type (2021-2032)
- 11.1.2 Asia Tenapanor Sales by Type (2021-2032)
- 11.1.3 Asia Tenapanor Price by Type (2021-2032)
- 11.2 Asia Tenapanor Market Size by Application
- 11.2.1 Asia Tenapanor Revenue by Application (2021-2032)
- 11.2.2 Asia Tenapanor Sales by Application (2021-2032)
- 11.2.3 Asia Tenapanor Price by Application (2021-2032)
- 11.3 Asia Tenapanor Market Size by Country
- 11.3.1 Asia Tenapanor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Tenapanor Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Tenapanor Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Tenapanor Market Size by Type
- 12.1.1 SAMEA Tenapanor Revenue by Type (2021-2032)
- 12.1.2 SAMEA Tenapanor Sales by Type (2021-2032)
- 12.1.3 SAMEA Tenapanor Price by Type (2021-2032)
- 12.2 SAMEA Tenapanor Market Size by Application
- 12.2.1 SAMEA Tenapanor Revenue by Application (2021-2032)
- 12.2.2 SAMEA Tenapanor Sales by Application (2021-2032)
- 12.2.3 SAMEA Tenapanor Price by Application (2021-2032)
- 12.3 SAMEA Tenapanor Market Size by Country
- 12.3.1 SAMEA Tenapanor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Tenapanor Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Tenapanor Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Tenapanor Value Chain Analysis
- 13.1.1 Tenapanor Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Tenapanor Production Mode & Process
- 13.2 Tenapanor Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Tenapanor Distributors
- 13.2.3 Tenapanor Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst